Mind Medicine (Mind Medicine) Change In Payables And Accrued Expense : $5.24 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine Change In Payables And Accrued Expense?

Mind Medicine's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $-1.19 Mil. It means Mind Medicine's Accounts Payable & Accrued Expense declined by $1.19 Mil from Dec. 2023 to Mar. 2024 .

Mind Medicine's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $7.34 Mil. It means Mind Medicine's Accounts Payable & Accrued Expense increased by $7.34 Mil from Dec. 2022 to Dec. 2023 .

Mind Medicine Change In Payables And Accrued Expense Historical Data

The historical data trend for Mind Medicine's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Change In Payables And Accrued Expense Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

3.43

5.20

-2.47

7.34

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial													0.91	9.44	-1.08	-1.93	-1.19

Mind Medicine Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.24 Mil.

Mind Medicine Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (Mind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.